Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade D 0.8551 -0.83% -0.01
ACST closed down 0.83 percent on Friday, May 17, 2019, on 63 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
14 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ACST trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
200 DMA Resistance Bearish -0.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.83%
Crossed Above 20 DMA Bullish -0.83%
New Uptrend Bullish -0.83%
Pocket Pivot Bullish Swing Setup -0.83%
Gapped Up Strength -0.83%
Up 3 Days in a Row Strength -0.83%

Older signals for ACST ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:

Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Medicine Chemistry Health Biopharmaceutical Cardiovascular Disease Lipid Cardiovascular Disorders Fatty Acids Hypertriglyceridemia Omega 3 Fatty Acid
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
May 15 Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
May 10 Neptune settles dispute with former CEO
May 10 Acasti Settles Claims with Former Chief Executive Officer
Apr 24 Acasti Pharma CEO to Present at the ThinkEquity Conference on May 2nd in New York City
Apr 15 Acasti Pharma advancing development of CaPre for high triglycerides
Apr 15 Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
Apr 1 Acasti Pharma Announces Publication of CaPre Bioavailability Study in Leading Peer-Reviewed Journal
Mar 26 Acasti Pharma to Present at the 2019 Spring Investor Summit in New York City on April 2nd
Mar 13 Acasti Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference on March 19th
Feb 21 Acasti Pharma Recognized in TSX Venture Exchange’s 2019 Venture 50
See more ACST news...
Indicators
Indicator Value
52 Week High 1.8
52 Week Low 0.43
Average Volume 250,341
200-Day Moving Average 0.8744
50-Day Moving Average 0.9466
20-Day Moving Average 0.8509
10-Day Moving Average 0.8223
Average True Range 0.0428
ADX 37.92
+DI 22.3468
-DI 19.451
Chandelier Exit (Long, 3 ATRs ) 0.8416
Chandelier Exit (Short, 3 ATRs ) 0.8929
Upper Bollinger Band 0.9252
Lower Bollinger Band 0.7766
Percent B (%b) 0.53
BandWidth 17.463862
MACD Line -0.0316
MACD Signal Line -0.0394
MACD Histogram 0.0078
Fundamentals Value
Market Cap 12.58 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.11
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.89
Resistance 3 (R3) 0.89 0.88 0.89
Resistance 2 (R2) 0.88 0.88 0.88 0.88
Resistance 1 (R1) 0.87 0.87 0.87 0.87 0.88
Pivot Point 0.86 0.86 0.86 0.86 0.86
Support 1 (S1) 0.85 0.85 0.84 0.84 0.83
Support 2 (S2) 0.84 0.84 0.83 0.83
Support 3 (S3) 0.82 0.84 0.82
Support 4 (S4) 0.82